Skip to content

Clinical trials

Hyperinsulinism trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hyperinsulinism Clear all

112 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20004
20021
20032
20043
20052
20062
20072
20083
20095
20101
20113
20122
20133
20142
20152
20165
20176
20184
20194
20202
20215
20226
20238
202411
20253
20265

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed64
Recruiting17
Withdrawn7
Unknown status7
Active, not recruiting5
Terminated5
Not yet recruiting3
Available2
Enrolling by invitation1
No longer available1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Columbia University10
Children's Hospital of Philadelphia8
National Heart, Lung, and Blood Institute (NHLBI)4
Rezolute4
Diva De Leon3
Maastricht University Medical Center3
University Hospital, Basel, Switzerland3
Yale University3
Montefiore Medical Center2
National Center for Research Resources (NCRR)2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hyperinsulinism112
Insulin Resistance48
Obesity26
Hypoglycemia19
Diabetes Mellitus18
Diabetes Mellitus, Type 218
Congenital Hyperinsulinism12
Hyperglycemia12
Glucose Metabolism Disorders11
Cardiovascular Diseases9

Trials

Showing 76 to 100 of 112. Each trial links to its page on Pharma Observatory.

12 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.